Clinical Trials on Relapsed or Refractory Neuroblastoma
Total 3766 results
-
Eucure (Beijing) Biopharma Co., LtdRecruitingAdvanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin LymphomaChina
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
Janssen Biotech, Inc.Pharmacyclics LLC.Approved for marketingRelapsed or Refractory Mantle Cell LymphomaUnited States, Brazil, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell LeukemiaUnited States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
US Oncology ResearchEli Lilly and CompanyCompletedRelapsed or Refractory Mantle Cell Lymphoma (MCL)
-
Shanghai Unicar-Therapy Bio-medicine Technology...RecruitingRelapsed or Refractory Non-Hodgkin's LymphomaChina
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
Hebei Yanda Ludaopei HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.TerminatedRefractory and Relapsed B Cell Acute LeukemiaChina
-
Hrain Biotechnology Co., Ltd.Shanghai Changzheng HospitalActive, not recruitingPOMES Syndrome | Relapsed and Refractory POMES SyndromeChina
-
Fujian Medical UniversityUnknown
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)China
-
Cellular Biomedicine Group Ltd.Chinese PLA General HospitalUnknownRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Juventas Cell Therapy Ltd.CompletedRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Giselle ShollerWithdrawnRelapsed NeuroblastomaUnited States
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada
-
Byondis B.V.RecruitingRelapsed / Refractory AML | Relapsed / Refractory MDSSpain, Netherlands, Belgium
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Follicular Lymphoma | Relapsed/Refractory Large B Cell LymphomaUnited States
-
University of Colorado, DenverColorado Department of Public Health and EnvironmentUnknownEpilepsy, Unspecified, Refractory (Medically)United States
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
University of WashingtonAbbVieSuspendedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Mixed Phenotype Acute Leukemia | Myeloid Neoplasm | Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia | Relapsed Acute Myeloid Leukemia | Mixed Phenotype Acute Leukemia | Relapsed Acute Biphenotypic Leukemia | Relapsed... and other conditionsUnited States
-
Beijing Boren HospitalTerminatedAdvanced Solid Tumor | Relapsed/Refractory LymphomaChina
-
Ruijin HospitalNot yet recruitingRelapsed or Refractory B-cell LymphomaChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsCompletedRecurrent or Refractory Solid Tumors | CNS MalignanciesUnited States
-
Juventas Cell Therapy Ltd.RecruitingRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
University of PennsylvaniaTerminatedRelapsed or Refractory B-cell Acute Lymphoblastic LeukemiaUnited States
-
Prof. Dr. Richard F SchlenkTerminatedAML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)Germany
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.Active, not recruitingRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaChina
-
Sierra Oncology, Inc.TerminatedRelapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Shanghai Unicar-Therapy Bio-medicine Technology...Peking University People's Hospital; The First Affiliated Hospital of Soochow...Not yet recruitingRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Changhai HospitalNot yet recruitingRelapsed or Refractory B-cell Lymphoma
-
Ruijin HospitalRecruitingRelapsed or Refractory B-cell LymphomaChina
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
Autolus LimitedActive, not recruitingRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaUnited States, United Kingdom, Spain
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Lymphoblastic Leukemia, in Relapse | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphocytic Leukaemia RefractoryChina
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Peking Union Medical College HospitalNot yet recruitingLocally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid CarcinomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (Relapsed/Refractory)China
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaboratorsCompletedSolid Tumors | Relapsed/Refractory SarcomasUnited States, Canada
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
Syndax PharmaceuticalsAvailable